Novabay Pharmaceuticals Inc

ASE:NBY   3:45:20 PM EDT
0.11
-0.01 (-8.48%)
Equity Financing / Related

NovaBay Pharma CEO Issues Letter To Stockholders

Published: 09/22/2022 20:11 GMT
Novabay Pharmaceuticals Inc (NBY) - Novabay Pharmaceuticals CEO Issues Letter to Stockholders.
Novabay Pharmaceuticals Inc - in Connection With Financing Transactions, We Are Required to Seek Stockholder Approval of a Reverse Stock Split.
Novabay Pharmaceuticals- Large Seasonal Order From Costco for Dermadoctor's Top-selling Product, Kakadu C, Will Increase Revenue in Third and Fourth Qtrs.
Novabay Pharmaceuticals Inc - Believe That a Reverse Stock Split May Improve Marketability and Liquidity of Our Common Stock.
Novabay Pharmaceuticals Inc- Generally Expect a Spike in Dermadoctor Sales During Fall.
Novabay Pharmaceuticals Inc- Expect Continued Growth Through 2022 and Into 2023.